Effect of nanoparticle size on the extravasation and the photothrombic activity of meso(p-tetracarboxyphenyl)porphyrin

Journal of Photochemistry and Photobiology B: Biology

Volumn 85, Issue 3, 2006, Pages 216-222

  Pegaz, Bernadette ^a   Debefve, Elodie ^a   Ballini, Jean Pierre ^a   Konan Kouakou, Yvette Niamien ^a   van den Bergh, Hubert ^a  

^a EPFL   (Switzerland)

Author keywords

Chicken embryo; meso tetra(carboxyphenyl)porphyrin; Nanoparticles; Particle size; Photodynamic therapy; Photosensitizer

Indexed keywords

DRUG CARRIER; MESO TETRAKIS(4 CARBOXYPHENYL)PORPHYRIN; NANOPARTICLE; PHOTOSENSITIZING AGENT; RESOMER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL INJURY; BLOOD VESSEL OCCLUSION; CHICKEN; CHORIOALLANTOIS; DIFFUSION; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG EXTRAVASATION; DRUG FORMULATION; EMBRYO; EMULSION; FLUORESCENCE MICROSCOPY; LIGHT EXPOSURE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL NEOVASCULARIZATION; THROMBOSIS;

ANIMALS; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; DRUG DELIVERY SYSTEMS; EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS; MICROSCOPY, FLUORESCENCE; NANOPARTICLES; NEOVASCULARIZATION, PATHOLOGIC; PARTICLE SIZE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; THROMBOSIS;

TETRA;

EID: 33750034336     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jphotobiol.2006.07.008     Document Type: Article

References (31)

1. Bressler N.M. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2. Am. J. Ophthalmol. 133 (2002) 168-169
2. Bressler N.M., Bressler S.B., and Fine S.L. Age-related macular degeneration. Surv. Ophthalmol. 32 (1988) 375-413
3. Renno R.Z., and Miller J.W. Photosensitizer delivery for photodynamic therapy of choroidal neovascularization. Adv. Drug Deliv. Rev. 52 (2001) 63-78
4. Allemann E., Rousseau J., Brasseur N., Kudrevich S.V., Lewis K., and van Lier J.E. Photodynamic therapy of tumours with hexadecafluoro zinc phthalocynine formulated in PEG-coated poly(lactic acid) nanoparticles. Int. J. Cancer 66 (1996) 821-824
5. Konan Y.N., Berton M., Gurny R., and Allemann E. Enhanced photodynamic activity of meso-tetra(4-hydroxyphenyl)porphyrin by incorporation into sub-200 nm nanoparticles. Eur. J. Pharm. Sci. 18 (2003) 241-249
6. Pegaz B., Debefve E., Borle F., Ballini J.P., van den Bergh H., and Kouakou-Konan Y.N. Encapsulation of porphyrins and chlorins in biodegradable nanoparticles: the effect of dye lipophilicity on the extravasation and the photothrombic activity. A comparative study. J. Photochem. Photobiol. B 80 (2005) 19-27
7. Vargas A., Pegaz B., Debefve E., Konan-Kouakou Y., Lange N., Ballini J.P., van den Bergh H., Gurny R., and Delie F. Improved photodynamic activity of porphyrin loaded into nanoparticles: an in vivo evaluation using chick embryos. Int. J. Pharm. 286 (2004) 131-145
8. Konan-Kouakou Y., Boch R., Gurny R., and Allemann E. In vitro and in vivo activities of verteporfin-loaded nanoparticles. J. Controlled Release 103 (2005) 83-91
9. Hammer-Wilson M.J., Akian L., Espinoza J., Kimel S., and Berns M.W. Photodynamic parameters in the chick chorioallantoic membrane (CAM) bioassay for topically applied photosensitizers. J. Photochem. Photobiol. B 53 (1999) 44-52
10. Ribatti D., Nico B., Vacca A., Roncali L., Burri P.H., and Djonov V. Chorioallantoic membrane capillary bed: a useful target for studying angiogenesis and anti-angiogenesis in vivo. Anat. Rec. 264 (2001) 317-324
11. Toledano H., Edrei R., and Kimel S. Photodynamic damage by liposome-bound porphycenes: comparison between in vitro and in vivo models. J. Photochem. Photobiol. B 42 (1998) 20-27
12. Lange N., Ballini J.P., Wagnieres G., and van den Bergh H. A new drug-screening procedure for photosensitizing agents used in photodynamic therapy for CNV. Invest. Ophthalmol. Vis. Sci. 42 (2001) 38-46
13. Pegaz B., Debefve E., Borle F., Ballini J.P., Wagnieres G., Spaniol S., Albrecht V., Scheglmann D., Nifantiev N.E., van den Bergh H., and Konan Y.N. Preclinical evaluation of a novel water-soluble chlorin E6 derivative (BLC 1010) as photosensitizer for the closure of the neovessels. Photochem. Photobiol. 81 (2005) 1505-1510
14. Allemann E., Doelker E., and Gurny R. Drug loaded poly (Lactic Acid) nanoparticles produced by a reversible salting-out process - purification of an injectable dosage form. Eur. J. Pharm. Biopharm. 39 (1993) 13-18
15. Allemann E., Gurny R., and Doelker E. Preparation of aqueous polymeric nanodispersions by a reversible salting-out process - influence of process parameters on particle-size. Int. J. Pharm. 87 (1992) 247-253
16. Ibrahim H., Bindschaedler C., Doelker E., Buri P., and Gurny R. Aqueous nanodispersions prepared by a salting-out process. Int. J. Pharm. 87 (1992) 239-246
17. Quintanar-Guerrero D., Allemann E., Fessi H., and Doelker E. Preparation techniques and mechanisms of formation of biodegradable nanoparticles from preformed polymers. Drug Dev. Ind. Pharm. 24 (1998) 1113-1128
18. De Jaeghere F., Allemann E., Leroux J.C., Stevels W., Feijen J., Doelker E., and Gurny R. Formulation and lyoprotection of poly (lactic acid-co-ethylene oxide) nanoparticles: influence on physical stability and in vitro cell uptake. Pharm. Res. 16 (1999) 859-866
19. Carpenter J.F., Pikal M.J., Chang B.S., and Randolph T.W. Rational design of stable lyophilized protein formulations: some practical advice. Pharm. Res. 14 (1997) 969-975
20. Konan Y.N., Gurny R., and Allemann E. Preparation and characterization of sterile and freeze-dried sub-200 nm nanoparticles. Int. J. Pharm. 233 (2002) 239-252
21. Leroux J.C., De Jaeghere F., Anner B., Doelker E., and Gurny R. An investigation on the role of plasma and serum opsonins on the internalization of biodegradable poly (d,l-lactic acid) nanoparticles by human monocytes. Life Sci. 57 (1995) 695-703
22. Romanoff A.L. Biochemistry of the Avian Embryo: A Quantitative Analysis of Prenatal Development (1967), John Wiley & Sons, New York
23. Leroux J.C., Allemann E., Doelker E., and Gurny R. New approach for the preparation of nanoparticles by an emulsification-diffusion method. Eur. J. Pharm. Biopharm. 41 (1995) 14-18
24. Kazuko Uchiyama A.N., Yamagiwa Y., Nishida T., Harashima H., and Kiwada H. Effects of the size and fluidity of liposomes on their accumulation in tumors: a presumption of their interaction with tumors. Int. J. Pharm. 121 (1995) 195-203
25. Blunk T., Hochstrasser D.F., Sanchez J.C., Muller B.W., and Muller R.H. Colloidal carriers for intravenous drug targeting: plasma protein adsorption patterns on surface-modified latex particles evaluated by two-dimensional polyacrylamide gel electrophoresis. Electrophoresis 14 (1993) 1382-1387
26. Harashima H., and Kiwada H. Liposomal targeting and drug delivery: kinetic consideration. Adv. Drug Deliv. Rev. 19 (1996) 425-444
27. Rudt S., and Muller R.H. Invitro phagocytosis assay of nanoparticles and microparticles by chemiluminescence .1. effect of analytical parameters, particle-size and particle concentration. J. Controlled Release 22 (1992) 263-271
28. Harashima H., Ohnishi Y., and Kiwada H. In vivo evaluation of the effect of the size and opsonization on the hepatic extraction of liposomes in rats: an application of Oldendorf method. Biopharm. Drug Dispos. 13 (1992) 549-553
29. Harashima H., Sakata K., and Kiwada H. Distinction between the depletion of opsonins and the saturation of uptake in the dose-dependent hepatic uptake of liposomes. Pharm. Res. 10 (1993) 606-610
30. Westedt U., Barbu-Tudoran L., Schaper A.K., Kalinowski M., Alfke H., and Kissel T. Deposition of nanoparticles in the arterial vessel by porous balloon catheters: localization by confocal laser scanning microscopy and transmission electron microscopy. AAPS. Pharm. Sci. 4 (2002) E41
31. R. Maassen, Mesoscopic particles in polymer solutions, thesis 2002, uni-duesseldorf (DE).